Close Menu

Sema4: Isaac Ro

Isaac Ro has been appointed as CFO of Sema4. Previously, he was CFO of Thrive Earlier Detection, which was recently acquired by Exact Sciences. Prior to that, he led the US medical technology team at Goldman Sachs, where he covered life science tools, diagnostics, and medical technology. Before that, he held a similar role at SVB Leerink.


Sophia Genetics: Ross Muken

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.